Evidence map›Paper›PMID 39557760›Full record

ArticleJournal of cancer survivorship : research and practice2026

Group medical visits in cancer survivorship care: a scoping review.

Niharika Dixit, Leslie Avilez, Vlad Honcharov, Kevin Knopf, Teja Bedi, Larissa Nekhlyudov, Urmimala Sarkar

Abstract readScoping Review
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Niharika DixitUniversity of California San Francisco/Zuckerberg San Francisco General Hospital, San Francisco, CA, USA. Niharika.dixit@ucsf.edu.
Leslie AvilezDivision of Internal Medicine, University of California, San Francisco, San Francisco, CA, USA.
Vlad HoncharovDivision of Internal Medicine, University of California, San Francisco, San Francisco, CA, USA.
Kevin KnopfDepartment of Medicine, Alameda Health System - Highland Hospital, Oakland, CA, USA.
Teja BediSan Mateo Medical Center, San Mateo, CA, USA.
Larissa NekhlyudovDepartment of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
Urmimala SarkarDivision of General Internal Medicine, Department of Medicine, University of California San Francisco, San Francisco, CA, USA.

Funding

Cancer Registry for Understanding and Improving Survivorship Experiences (CRUISE)R01CA241128 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOMEZ, SCARLETT L, SARKAR, URMIMALA · 2019 to 2023
$3.2M
NCI NIH HHS R01 CA241128
6 · The paper itself

Abstract

backgroundMore than 60% of cancer survivors report unmet physical, psychosocial, and informational needs. The care of cancer survivors includes surveillance, health maintenance monitoring, referral for long-term adverse effects of cancer treatment, and coordination of care. Group medical visits (GMV) include medical care, education, and peer support and can be used to facilitate the delivery of multidisciplinary survivorship care. We aimed to characterize the current state of related research describing the role of GMV in cancer survivorship care.

methodsFor this scoping review, we searched for published literature using PubMed, Embase, and other resources. We included intervention studies of multidisciplinary care involving GMVs of adult patients with a history of cancer requiring the presence of medical personnel, physicians, advanced practitioners, or oncology nurses. We included studies that focused on broad cancer survivorship care, rather than those using specific modalities, such as yoga, or limited to specific aspects of cancer survivorship care, such as weight loss. We characterized the studies by cancer type, structure of GMVs, and reported outcomes.

resultsWe identified 2311 studies (2122 from PubMed and 189 from Embase). We excluded 1524 duplicates and screened 787 studies for title and abstract review. Finally, 63 studies were retrieved for full-text review, and six were included in this scoping review. Of the included studies, four were non-randomized, and two were randomized. Breast cancer was the most common site (4); other studies included breast and other cancers (1) and hematopoietic transplant cancer survivors (1). There was heterogeneity in the structure and frequency of sessions and the survivorship domains addressed. The outcomes studied included quality of life, healthcare utilization, and costs.

conclusionsLimited high-quality research exists on the role of GMV in cancer survivorship. Though shown to be effective in chronic disease, the evidence for the effectiveness of this important and widely used approach in multidisciplinary survivorship care remains inconsistent and preliminary; the literature to date provides a starting point for larger-scale studies of GMV in cancer survivorship care. IMPLICATIONS FOR CANCER SURVIVORS: While Group medical visits are a promising intervention to provide multidisciplinary care, larger studies are needed to support their benefit in the care of cancer survivors.

Indexed as

Cancer SurvivorsNeoplasmsSurvivorshipHumansCancer survivorshipGroup medical visitsMultidisciplinary careShared medical visitsSurvivors

Identifiers

PMID39557760
PMCPMC12711253

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.